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Abstract Sexual concerns are known to be common in women suffering from multiple
sclerosis (MS) but definite data on the prevalence of particular sexual dysfunctions (SD)
remain unclear. Previous studies brought inconsistent findings and rely on small groups
of patients or use of unvalidated assessment methods. The aim of this research was to
evaluate the prevalence of SD in women with MS using validated clinimetric scales. 137
female inpatients with MS diagnosis were interviewed, completed The Female Sexual
Function Questionnaire SFQ28 and underwent neurological assessment. Only 2.2 % of
patients had ever discussed their sexual concerns with a physician. 70.1 % reported sexual
activity. At least one SD could be found in 82.5 % of patients, hypoactive sexual desire
(57.7 %), arousal dysfunction (decreased genital sensation in 47.3 %, decreased lubrica-
tion in 48.4 %, decreased subjective arousal in 45.2 %) and orgasmic dysfunction (39.8 %)
being the most probable. SD were less likely in women who assessed their relationship
positively but more common in older patients and those who had a positive history of
depression. The prevalence of SD was higher comparing to the majority of studies by other
authors. In conclusion, SD are very common in female patients with MS and permanently
overlooked by medical professionals. Therefore, the assessment of sexual function should
be implemented in all patients after the diagnosis of MS. Further research is needed for
better understanding of the sexuality of this particular population in order to establish
targets for therapeutic intervention.
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Introduction
Sexual activity has had a strong impact when it comes to determining a basic quality of
life, self-esteem, self-image and quality of interpersonal relationships. According to
research in this area, individuals with sexual dysfunctions (SD) have a diminished quality
of life compared to others and show poorer outcomes in all major dimensions determining
wellbeing like health, achievements, personal relationships, safety and a feeling of being a
part of their community [1]. Based on research by McCabe and Taleporos on 1,196
subjects, it was demonstrated that people who had more severe physical impairments and
who had significantly lower levels of sexual esteem and sexual satisfaction were sexually
active less frequently and more depressed than able-bodied people [2]. The negative
influence of a set of comorbidities such as depression, cardiovascular disease and diabetes
mellitus on sexual function is well known [3–7]. Sexual concerns of patients suffering from
a neurological disease (especially polyneuropathies and myelopathies) are common [8, 9],
but still remain poorly understood in clinical practice.
It has been known for a long time that SD in women with multiple sclerosis (MS) are
more prevalent than in the general population [10]. They are thought to be derived from
disease-related neurologic changes—demyelination and the atrophy of nerve fibers that
impact sexual response (primarily SD), fatigue and physical disability related to MS
(secondary SD). This would also apply to psychological and sociocultural aspects of a
chronic disease (tertiary SD) [11, 12]. The disease-specific neurologic lesions affecting
sexual activity can be localized in the brain, spinal cord or peripheral neurons. Autonomic
fiber injuries can also cause SD accompanied by bladder and bowel incontinence that
contribute to physical discomfort (i.e. fear from unwanted urination or defecation) during
intercourse [10, 13]. In a recent study of 19 men and 52 women with MS by Khan and
colleagues [14] significant negative correlations between the Total Personal Experiences
Questionnaire (PEQ) Sexual Frequency scale and Neurological Disability Scale (q =
-0.30) were found. The scores in the PEQ Sexual Frequency scale also correlated nega-
tively with the Quality of life item from the American Urological Association Bladder
score (q = -0.35) and with the MS Impact Scale Physical subscale (q = -0.30). Khan
and colleagues concluded that the demyelinating lesions causing physical impairments and
bladder dysfunction in MS may also affect SD.
Symptoms of weakness of the pelvic floor, bladder and bowel dysfunction are correlated
with changes in lubrication and orgasmic capacity. Lesions in the sacral segments of the
spinal cord that affect the sacral reflex arc, clitoral and vaginal sensory deficits may cause
decreased physical arousal (lubrication, sensations) and anorgasmia. Spasticity, impaired
mobility and coordination, fatigue, pain, numbness and weakness of pelvic floor muscles
are other factors that affect satisfactory intercourse [15–17]. The tertiary SD (psychological
and sociocultural aspects) include negative changes in mood (depressive mood) and self-
image, feeling less attractive, changing gender roles and roles in the couple, difficulties in
communicating with one’s partner, feelings of guilt, dependency and fear of being sexually
rejected, abandoned or isolated [11]. Nearly half of all patients with MS report mental
comorbidity along with depression as the most common—an estimated 46 % in a study of
8,983 MS patients by Marrie and colleagues [18].
SD in women with MS as well as other neurological diseases was further investigated
by several authors. However, most studies rely on small groups of patients and author-
designed interviews or questionnaires. The frequency of SD in women with MS was
recently reviewed by Bronner and colleagues [19] and a wide variety of studies by different
authors indicate significant differences in estimation of decrease in sexual desire
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(31.4–63.6 %) [13, 20–24] and impaired arousal (33.0–51.5 %) [20, 22–25]. However, this
was seen to a much lesser extent when it came to evaluating orgasmic difficulties
(37.0–38.3 %) [20, 22, 23].
Using unvalidated questionnaires in SD epidemiological studies is especially prob-
lematic as the definition and criteria of SD often remain unclear. Classifications introduced
by the World Health Organization (ICD-10) [26] and the American Psychiatric Association
(DSM-IV) [27] have created definitions for SD based mainly upon the physiological model
of genital responses and symptoms that serve to hinder coital intercourse. Both sets regard
SD involving various combinations of physical and psychological constituents. However, it
remains controversial that they believe it is possible to separate these [28]. For epidemi-
ological purposes, it is important to use a well-recognized and validated set of screening
tools that involve both physical and psychological aspects of SD. This will allow for the
creation of comparable databases of SD in certain populations that could be further ana-
lyzed in order to draw clinical implications.
The aim of our research was to accurately evaluate the prevalence of SD in women with
MS. To our knowledge, our group is the largest sample of women with MS investigated for
SD in a single study with a validated questionnaire.
Material and Methodology
One hundred and thirty-seven women with MS have been included in the study. The
diagnosis was established according to the McDonald‘s diagnostic criteria for MS. These
criteria require evidence for at least two episodes of neurological dysfunction (dissemi-
nation in time, DIT) with the involvement of two different brain regions (dissemination in
space, DIS) and MRI confirmation of substantial numbers of demyelination foci in the
central nervous system [29]. All of the patients fulfilled the diagnostic criteria for the MS
and were patients of the National Multiple Sclerosis Center in Dabek, Poland. Mean
disease duration time was 16.4 with a range of 3–38 years. The initial criterion for
inclusion involved a definite diagnosis of MS. After this, patients were informed about the
study methodology as well as its hypotheses and goals. Patients were then invited to ask
questions about the study where all of their concerns were clarified. Only adult patients
(age C 18) who had written informed consent were included. Patients who did not want to
participate in the study or could not give written informed consent were excluded.
Demographic data were obtained from semi-structured interviews and medical chart
review. The information that was collected included age, the onset of symptoms of MS,
comorbidities, concomitant medications, a history of depression (clinical diagnosis) and its
treatment, marital status and basic obstetric history. Patients were asked whether their
sexual life worsened since the onset of MS. They also assessed their current relationship by
choosing a description that best fits their perception: definitely negative, rather negative,
neutral, somewhat positive or definitely positive. Sexual activity was defined as an activity
that may lead to sexual arousal or sexual enjoyment that occurred during a 1 month period
before admission to the Rehabilitation Center. It included sexual intercourse, caressing and
masturbation.
Patients also completed The Female Sexual Function Questionnaire (SFQ28). The
results of it were further discussed with patients in order to ensure that the information
obtained was complete and reliable. SFQ28 is a self-report outcomes measure and
addresses all aspects of the female sexual response cycle (desire, arousal, orgasm) and pain
during sexual activity, according to DSM-IV diagnostic criteria. It also contains questions
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concerning their sexual enjoyment and relationship with a partner. It has also been used in
research regarding female sexual dysfunction (FSD) [30, 31]. The psychometric properties
of the SFQ28 were recently assessed by Symonds and colleagues [32] in female sexual
arousal disorder (FSAD) candidates and in hypoactive sexual desire disorder (HSDD)
populations. The factor analysis confirmed the factor structure of the questionnaire. The
SFQ28 demonstrated excellent internal consistency with the Cronbach’s alpha coefficient
for each of the domains ranging from 0.70 to 0.93 for subjects with FSAD and from 0.72 to
0.90 for subjects with HSDD. The test–retest reliability was also very strong for each
domain involving subjects with FSAD and HSDD. SFQ28 also had good convergent
validity with other scales like the Female Sexual Distress Scale (FSDS) and the Sexual
Quality of Life-Female (SQOL-F) scale for all domains except pain. The SFQ is recom-
mended as the optimal screening tool for female sexual dysfunction [33] and the Polish
version of the questionnaire was recently validated with an estimated reliability of level
0.97 (Cronbach’s alpha test) [34]. In our study, the alpha coefficient value was 0.98.
The SFQ28 contains 28 items and each item represents five or seven possible response
options. Results of the SFQ28 are presented in seven domains: Desire, Arousal (sensation),
Arousal (lubrication), Arousal (cognitive), Orgasm, Pain, Enjoyment and Partner. Desire
domain (six items), addresses pleasurable thoughts and feelings concerning sexual activity,
a need to be intimately touched, to participate in sexual activity, initiate sexual activity,
and sexual frequency and willingness for sexual activity. Arousal—sensation (four items)
refers to feelings of warmth and pulsation within the genital area, and their intensity.
Arousal—lubrication (two items) is considered when analyzing the frequency and intensity
of vaginal wetness during sexual activity. Arousal—cognitive domain (two items) also
reflect the frequency and intensity of emotional sexual arousal (feeling excited, ‘‘turned
on’’ etc.). Orgasm domain (three items) concerns the frequency, ease and pleasure of
having an orgasm during sexual activity. Pain domain (three items) concerns the frequency
and intensity of experiencing pain in the vagina or genital area during or after sexual
activity, as well as any anxiety related to pain. The enjoyment domain (six items) reflects
enjoyable feelings of being sexually touched or caressed by the partner, enjoyment of
sexual activity with or without penetration, feelings of emotional closeness to the partner
when taking part in sexual activity, and feeling good about herself and confident as a
partner during sexual activity. Partner domain (two items) refers to a patient’s worries
regarding how negatively they perceive their partner feels during sexual activity and their
level of insecurity in keeping their relationship due to problems in their sexual life [31, 34].
The higher score indicates a better sexual function. Scores for the categories of: Desire,
Arousal, Orgasm, Pain and Enjoyment are further subdivided into three categories that
include: a high probability of FSD, borderline sexual function and high probability of
normal sexual function (Table 1) [30, 31]. There are also no score ranges for Partner
domain and for a total score of the SFQ28. Higher scores are interpreted as a better
assessment of the relationship and indicate less sexual dysfunction, respectively.
An Expanded Disability Status Scale (EDSS) was performed by the one and only
independent rater (neurologist) according to the method described originally by John
Kurtzke [35]. EDSS is the most frequently used scale when it comes to the assessment and
quantification of symptoms’ severity and physical functioning of patients with MS. EDSS
scoring is based on measuring the everyday activities (ambulation with or without walking
aids, walking distance, need for assistance and help with walking), physical functioning
and neurological symptoms, such as: pyramidal, cerebellar, brainstem, sensory, bowel and
bladder, visual and psychiatric dysfunction. A final score is presented numerically on a
scale of 0–10 where 0 stands for normal functioning without any neurological deficits and
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10 represents ‘‘death due to MS’’. Therefore, EDSS covers both the physical functioning
and severity of the symptoms for patients with MS [35]. Three (3) out of 137 patients
refused to participate in the neurological evaluation. Furthermore, an independent rater did
not have any insight into their medical history, observation, type of the disease course,
disease duration, and results of their sexual function evaluation.
Statistical analysis was performed using a Graph Pad In Stat 3.06 for Windows and
SPSS 20.0. Frequencies were then calculated for each variable. The data was presented in
the paper using means and standard deviation. Values sampled from normal (Gaussian)
distributions were appropriately compared using a Student’s t test and ANOVA measures
followed by Tukey post hoc tests. Values without normal distributions were compared by
nonparametric tests: Mann–Whitney-U test and Kruskal–Wallis test followed by a Dunn
post hoc test. Only measures with a p \ 0.05 were considered statistically significant.
Results
One hundred and thirty-seven women with MS completed the study. The mean age of
participants was 50.7 ± 7.0, disease duration 16.4 ± 8.6, age of MS onset 34.7 ± 9.2 and
relationship duration 24.5 ± 10.5 years. The mean EDSS score was 5.2 ± 0.2 points. 94
patients reported concomitant morbidities where the most frequent were: history of
depression (30 patients), hypertension (15) and osteoarthritis (10).
Sexual activity was reported by 96 women (70.1 %). Among patients living in stable
relationships, 85 % were sexually active compared to (0 %) of single and widowed
women. Typical frequency of sexual activity is shown in Fig. 1. Only nine (6.6 %) of the
patients reported masturbating. All of them were in stable relationships, and seven
(77.8 %) had intercourse with their partners. Most of the women perceived their rela-
tionship as a positive experience: (40.2 % as definitely positive and 41.1 % as somewhat
positive, respectively), 10.7 % were neutral, 5.4 % were rather negative and only one
person (0.9 %) reported a definitely negative experience. Lastly, 1.8 % of the patients did
not respond to the questions.
The majority of all of the subjects (n = 121, 88.3 %) had children and 18 (13.1 %) had
a history of miscarriage (83.3 % occurred after the onset of MS). Only 43 (31.4 %) were
pregnant and 32 (23.4 %) gave birth after the onset of MS.










Desire 5–16 17–22 23–31
Arousal (S) 4–10 11–13 14–20
Arousal (L) 2–5 6–7 8–10
Arousal (C) 2–5 6–7 8–10
Orgasm 1–8 9–11 12–15
Pain 2–8 9–11 12–15
Enjoyment 6–16 17–22 23–30
Arousal Domains, S sensation, L lubrication, C cognitive
Sex Disabil (2013) 31:141–153 145
123
The data from SFQ28 are presented in Table 2. The percentages of high probability of
FSD, borderline SF and the high probability of normal SF in Partner Domain and total
score of SFQ28 are marked not available as there are no reference score ranges for these
domains. At least one sexual dysfunction (defined as high probability of FSD according to
scores in Desire, Arousal, Orgasm or Pain Domain of the SFQ28) could be found in 113
(82.5 %) of patients. About a half of the women (50.6 %) with a high probability of HSDD
according to SFQ28 were sexually active with their partners. The comparison performed
with Mann–Whitney-U test has shown that sexually active patients scored, on average,
much higher in the Desire Domain than those who denied having intercourse (16.9 ± 6.1
vs 8.6 ± 4.2, respectively) indicating a significantly better sexual function (p \ 0.0001).
Less than half of the subjects (41.5 %) claimed that their sexual life worsened. For
55.4 % it did not change, and for only 3.1 % it improved after the onset of MS. Women
who reported no change in their sexual life since the onset of MS scored significantly better
in SFQ28 than those who perceived that it had worsened: 16.3 ± 6.9 versus 12.4 ± 5.5 in
Desire (p \ 0.005; Mann–Whitney-U test), 11.8 ± 3.6 versus 9.9 ± 4.5 in Arousal—
sensation (p \ 0.05; Student-t test), 6.0 ± 2.0 versus 4.5 ± 2.0 in Arousal—lubrication
(p \ 0.005; Mann–Whitney-U test), 8.7 ± 3.9 versus 6.25 ± 4.3 in Orgasm (p \ 0.005;
Mann–Whitney-U test), 18.9 ± 5.3 versus 15.4 ± 5.9 in Enjoyment (p = 0,005; Mann–
Whitney-U test) and 95.0 ± 18.8 versus 83.1 ± 19.8 in SFQ28 total score (p \ 0.01;
Mann–Whitney-U test). The differences were not quite as significant in Arousal—cogni-
tive (5.8 ± 1.8 vs. 5.0 ± 2.2, respectively, p = 0.084; Mann–Whitney-U test) and Partner
Domain (9.0 ± 1.7 vs. 8.3 ± 2.0, respectively, p = 0,055; Mann–Whitney-U test). The
difference in the Pain Domain was insignificant.
A comparison of sexual function between age groups was shown in Table 3. The most
significant were the differences between the youngest (B 45 y.o.) and the oldest (C 56 y.o.)
group of patients in the categories of Desire and Arousal, as well as in their SFQ28 total score in
favor of the youngest. Patients with a positive history of depression (23.4 %) scored signifi-
cantly lower than the others in Desire (11.4 ± 6.2 vs. 15.3 ± 6.7, p \ 0.005; Mann–Whitney-
U test), Arousal—sensation (9.5 ± 4.9 vs. 11.6 ± 3.8, p \ 0.05; Student-t test) and
Enjoyment (14.7 ± 7.6 vs. 18.5 ± 5.2, p \ 0.01; Mann–Whitney-U test) domains of SFQ28.
The assessment of relationship experience in women with MS did not vary according to
their age or EDSS score (p [ 0.05), whereas SFQ28 scores were clearly different in patients
who assessed their relationships differently (Table 4). Only 3 (2.2 %) of all patients have ever
tried sexual or couple therapy including discussing their sexual issues with a physician,
psychologist, or physiotherapist.
Fig. 1 Sexual activity of women with MS during last month before examination
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Discussion
In the literature there are many studies on different health related subjects connected to MS
but very few facing sexual issues [36]. To date, research that uses large cohorts and
validated tools is specific to men with MS and relates mostly to erectile dysfunction. This
is surprising, as MS affects women more often than men. A possible explanation for this is
Table 3 Comparison of SFQ28 scores between age groups in women with MS
SFQ28 B 45 46–55 C 56
Domain score Age group Age group Age group
Desire** 16.6 ± 6.6 15.0 ± 6.6 11.7 ± 6.4
Arousal (sensation)* 12.5 ± 3.6 11.5 ± 3.7 9.3 ± 4.6
Arousal (lubrication)** 6.6 ± 2.1 5.5 ± 1.9 4.5 ± 2.2
Arousal (cognitive)** 6.5 ± 1.8 5.7 ± 1.8 4.5 ± 2.2
Orgasm* 8.7 ± 4.4 8.3 ± 4.0 6.2 ± 4.4
Pain* 14.3 ± 1.5 13.3 ± 1.9 12.3 ± 3.6
Enjoyment 19.3 ± 5.3 18.1 ± 5.8 15.3 ± 6.2
Partner 8.5 ± 1.9 9.0 ± 1.6 8.5 ± 2.0
SFQ28 total score* 99.4 ± 17.8 92.4 ± 17.7 81.0 ± 23.9
The scores are presented as means ± standard deviations
* Statistical significance p \ 0.05 between groups
** Statistical significance p \ 0.005 between groups
The analyses were performed using Kruskal–Wallis nonparametric test followed by Dunn post hoc test
except the comparison in Arousal-sensation domain which was performed using ANOVA followed by
Tukey post hoc test
Table 4 SFQ28 scores according to relationship assessment
Relationship assessment
Negative/neutral Somehow positive Very positive
Desire** 12.9 ± 5.6 14.4 ± 6.5 18.3 ± 5.8
Arousal (sensation)** 8.9 ± 4.3 10.0 ± 3.4 13.0 ± 3.9
Arousal (lubrication)* 4.2 ± 1.7 5.5 ± 2.2 6.0 ± 2.1
Arousal (cognitive)* 4.4 ± 2.25 5.3 ± 1.7 6.3 ± 2.0
Orgasm** 4.1 ± 3.4 7.8 ± 3.8 9.4 ± 4.1
Enjoyment** 11.7 ± 4.8 17.9 ± 5.2 20.5 ± 4.6
Pain* 12.2 ± 3.3 13.0 ± 2.5 14.0 ± 1.9
Partner 8.3 ± 2.3 8.7 ± 1.7 9.2 ± 2.3
SFQ28 total score** 68.8 ± 18.3 90.8 ± 15.8 98.3 ± 19.4
The scores are presented as means ± standard deviations
* Statistical significance p \ 0.05 between groups
** Statistical significance p \ 0.005 between groups
SFQ28 scores are presented as means ± standard deviations. The scores in Arousal (sensation) and
Enjoyment domains, and SFQ28 total score were compared within groups using ANOVA followed by
Tukey post hoc tests. Other domains were compared using Kruskal–Wallis nonparametric test followed by
Dunn post hoc test
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the influence of the pharmaceutical industry and the high demand for phosphodiesterase-5
inhibitors that catalysed studies on male SD and a search for target populations. Moreover,
according to Nortvedt and colleagues [37], men with MS can be much more dissatisfied
with their sexual functions than women with MS. This also makes them an easier target for
research. On the other hand, the studies on FSD were conducted for smaller groups often
using a less than reliable methodology (typically author-designed, short questionnaires).
Our study was intended to fill the gap in the research on sexual functioning in women with
MS. Another advantage is our patient sample size and use of reliable methodology for the
assessment of sexual function.
The vast majority (97.8 %) of our patients had neither tried sexual or couple therapy nor
discussed their sexual concerns with any physician, psychologist or physiotherapist. This
could be related to a relatively weak knowledge about sexual dysfunctions (SD) among
medical care professionals and serves as an embarrassment when discussing intimate topics
for both patients and physicians. On the other hand, the vast majority of patients believe
that it is appropriate for physicians to address sexual function within the context of a
routine health assessment [38]. This confirms the need for publishing more research on SD
in patients with different chronic illnesses, including MS.
82.5 % of our female patients have had a high probability of at least one sexual dys-
function. This prevalence is very high when compared to the most representative general
population-base studies where: an estimated 43 % of women suffering from sexual
problems according to the National Health and Social Life Survey (NHSLS) in the US [39]
and 44.2 % of women did indicate at least one sexual problem as reported by Shifren and
colleagues [40]. The prevalence of at least one SD in our patients is also higher than in
previous studies of women with MS published by Barak and colleagues (50.5 %) [41] and
Zorzon and colleagues (62.9 %) [20]. This could be due to different screening tools and a
slightly different characteristic of study groups. In the research made by Barak and col-
leagues, the evaluation of SD was limited to patients with relapsing-remitting MS and in
the study by Zorzon and colleagues, the mean EDSS score (2.6) was different than in our
patients.
Three of the most common sexual problems (low desire, reduced sexual arousal and
orgasm difficulties) were clearly higher in our patients than in the general population in the
NHSLS: 57.7 versus 38.7 %, 47.3/48.4 %/45.2 %1 versus 26.1 % and 39.8 versus 20.5 %,
respectively. The rates for decreased sexual desire, impaired arousal and difficulties in
achieving orgasm in our group were within the upper range or slightly over the range
estimated from reports by most of the other authors [13, 20–25]. Sexual pain was also not a
frequent complaint in our patients (5.7 %) and this could explain why it was also rarely
reported in any of the literature [19]. A higher prevalence of both decreased sexual desire
(59.6 %) and orgasmic dysfunction (38.3 % with diminished orgasmic capacity and
12.8 % with a complete lack of an orgasm) were reported by Hulter and Lundberg [23] but
they had examined women with more severe neurological impairments—a mean EDSS
score of 6.5 compared to 5.2 in our patients. More recently, FSD in patients with MS,
according to their hormonal status, were researched by Lombardi and colleagues [42].
Authors assessed 55 women using the Female Sexual Function Index, which is a well-
designed and validated questionnaire for the evaluation of FSD [43]. Like in our study,
they found desire to be the most affected domain of sexual functioning (57.4 %). However,
more than one-third of all patients examined by Lombardi and colleagues had abnormal
1 The rates represent arousal dysfunction in three different dimensions: sensation/lubrication/cognitive,
respectively.
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hormonal alterations; the correlations with sexual function were statistically insignificant,
which further confirms the assumption of a multifactorial etiology of SD in patients with
MS.
There are also different explanations for a higher prevalence of SD in our patients. First,
they could be functionally more impaired than participants of other studies, as they were all
recommended for rehabilitation. Second, we had used a validated tool for the assessment of
SD, which can be more sensitive than author-designed questionnaires or interviews. Some
other studies could also be biased as a result of using smaller study groups. And finally, we
did not exclude patients with concomitant diseases like diabetes or cardiovascular factors
that can independently cause SD.
Older patients scored lower in SFQ28 indicating more SD. That is consistent with a
common finding for a higher prevalence of SD in older people [44, 45]. It is also surprising
that over half of the patients claimed that the quality of their sexual life had not changed
since the onset of MS. In another study, one by Hennessey and colleagues [21]—half of the
female patients reported a deterioration of sexual activity while Zorzon and colleagues [20]
reported that 48.6 % of women with MS had an unchanged quality of sexual life. This was
further supported by much better results in most of the domains in SFQ28 compared to
women who perceived that their sexual life had worsened. Both subgroups did not differ
significantly in age and in duration of MS and EDSS score. It is understood that the course
of MS is very unpredictable with different functional deterioration dynamics that are
involved [46] so that the disease duration does not have to be a strong correlate with this
(apart from the psychological influence of a longer-lasting status of being ill). In fact, the
onset of the disease did not correlate significantly with their SFQ28 score. On the other
hand, a woman’s perception of her sexual life was found to be dependent upon many
different confounders like mood, quality of relationship or self-image, which makes this
evaluation less reliable. However, even in patients perceiving that their sexual life did not
change since the onset of MS, the prevalence of a highly probable sexual dysfunction was
higher when compared to the general population of Poland [47] (44 % vs. 25 % for
hypoactive sexual desire, 40 % vs. 12 % for decreased lubrication and 26 % vs. 10 % for
anorgasmia, respectively).
It is commonly agreed that sexual response and relationship issues such as intimacy,
attitudes and satisfaction strongly depend on each other [48]. According to McCabe and
colleagues, 71 % of patients with MS and SD have marital problems [49]. It is worth
emphasizing that in our study 81.3 % of females assessed their relationship with a partner
from a positive standpoint. They scored much better in Desire, Arousal, Orgasm, Pain and
Enjoyment domains of SFQ28 than patients who had a negative attitude towards their
relationships. The comparison was insignificant only for the Partner Domain. This could
seem surprising and suggested incoherence in their evaluation of the relationship between
the interviewer and SFQ28 questionnaire. However, the SFQ28 Partner Domain contains
two questions that relate to: (1) fear that the partner could search for another relation and,
(2) perception of a partner’s negative feelings regarding their sexual activity. These
questions do not evaluate the general quality of a relationship as it was obtained in an
interview with patients. To conclude, the assessment of a patient’s relationship does not
have to be coherent with SFQ28 Partner Domain.
The findings of our study confirm that SD is a serious problem in women suffering from
MS. The frequency of SD, especially HSDD, FSAD, and difficulties in achieving orgasm
and sexual enjoyment, is very high in patients with MS compared to the general popula-
tion. A higher prevalence of SD in patients with MS could also be found with the use of
more detailed and validated assessment methods. 97.8 % of our patients had never been
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asked before to discuss their sexuality in connection with their disease, which is similar to
94 % reported by Hulter and Lundberg [23] and 92.9 % reported by Zorzon et al. [20].
Medical professionals working with patients with MS should also pay more attention to
their sexual concerns. This lack of interest in SD prevents patients with MS from receiving
any professional therapy and could influence their quality of life negatively. These patients
could also be diagnosed more accurately when using the appropriate screening tools in a
routine examination of newly diagnosed MS during follow-up visits. Moreover, medical
professionals working in the field of MS should be educated about the specificity of SD in
patients with MS and how to screen them. The assessment of sexual function should also
be implemented in all patients after the diagnosis of MS as SD may cause personal distress
as well as relationship difficulties.
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